Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
RPTN - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TCHH - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
S100A11 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FLG - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
S100A10 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FLG-AS1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FLG2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CRNN - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
THEM4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
THEM5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RORC - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CRCT1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LCE3D - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LINC00302 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on